The net loss for Intellia Therapeutics in 2023 amounted to some 481 million U.S. dollars. The statistic illustrates the net loss for Intellia between 2014 and 2023. Intellia is a biotech company that produces therapeutics using CRISPR technology.
Net loss of Intellia Therapeutics from 2014 to 2023
(in million U.S. dollars)
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Intellia Therapeutics. (February 22, 2024). Net loss of Intellia Therapeutics from 2014 to 2023 (in million U.S. dollars) [Graph]. In Statista. Retrieved December 03, 2024, from https://www.statista.com/statistics/1097484/net-loss-intellia-therapeutics/
Intellia Therapeutics. "Net loss of Intellia Therapeutics from 2014 to 2023 (in million U.S. dollars)." Chart. February 22, 2024. Statista. Accessed December 03, 2024. https://www.statista.com/statistics/1097484/net-loss-intellia-therapeutics/
Intellia Therapeutics. (2024). Net loss of Intellia Therapeutics from 2014 to 2023 (in million U.S. dollars). Statista. Statista Inc.. Accessed: December 03, 2024. https://www.statista.com/statistics/1097484/net-loss-intellia-therapeutics/
Intellia Therapeutics. "Net Loss of Intellia Therapeutics from 2014 to 2023 (in Million U.S. Dollars)." Statista, Statista Inc., 22 Feb 2024, https://www.statista.com/statistics/1097484/net-loss-intellia-therapeutics/
Intellia Therapeutics, Net loss of Intellia Therapeutics from 2014 to 2023 (in million U.S. dollars) Statista, https://www.statista.com/statistics/1097484/net-loss-intellia-therapeutics/ (last visited December 03, 2024)
Net loss of Intellia Therapeutics from 2014 to 2023 (in million U.S. dollars) [Graph], Intellia Therapeutics, February 22, 2024. [Online]. Available: https://www.statista.com/statistics/1097484/net-loss-intellia-therapeutics/
